|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1000 - 0.1300|
|52 Week Range||0.0100 - 0.5000|
|Beta (5Y Monthly)||-1.06|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Data using XPRIZE supplied contrived fluid samples provides results comparable to those seen in the FDA lab testing of donor saliva, as DECN competes for the $5 million prize and GLOBAL validationLOS ANGELES, CA / ACCESSWIRE / November 23, 2020 / Decision Diagnostics Corp.
With Favorable Testing Results Anticipated on November 13 From Our FDA and CLIA Certified Laboratory, DECN Estimates Completion and Filing of 3rd FDA EUA Application in the Next 3 WeeksLOS ANGELES, CA / ACCESSWIRE / November 12, 2020 / Decision Diagnostics Corp.
Company Being Sought Out Worldwide for Global Distribution Agreements as It Enters the "Home Stretch" in U.